Company intelligence / Profile preview

iSeed Ventures

San Francisco, California, United Statesiseedvc.com ↗

Ownership: Private
Development stage: Preclinical

Overview

iSeed Ventures is a San Francisco-based venture capital firm founded in 2014 with over $200 million under management. The firm focuses on early-stage and seed investments across diverse sectors including digital health, healthcare IT, consumer technology, AI/deep tech, fintech, and education. It has backed companies such as mySugr (acquired by Roche), 1DocWay (acquired by United Healthcare), and 9am.health. While it invests in healthtech and wellness startups—including those developing digital health solutions—it does not itself conduct drug development or clinical trials.

Industry: Investors

Partnerships

Not directly disclosed; acts as an investor/partner to portfolio startups

Beyond the preview

Go deeper on iSeed Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on iSeed Ventures.

Explore the full profile